Researchers have investigated how AD pathologies such as tau neurofibrillary tangles (NFTs) and beta-amyloid (Aβ) plaques may accelerate cognitive dysfunction in brain regions that support WM. The gene discussed is MAPT; the disease is Alzheimer disease.